Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors.

about

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

P2860

Q58742961-4FA7369C-860E-46F4-88D5-7AA66D80AB06

P2860

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors.

Item

http://www.wikidata.org/entity/Q42378681

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Transforming Mutations of Jak3 ...... to Selective Jak3 Inhibitors.

@en

Transforming Mutations of Jak3

@nl

type

Item

label

Transforming Mutations of Jak3 ...... to Selective Jak3 Inhibitors.

@en

Transforming Mutations of Jak3

@nl

prefLabel

Transforming Mutations of Jak3 ...... to Selective Jak3 Inhibitors.

@en

Transforming Mutations of Jak3

@nl

P1476

Transforming Mutations of Jak3 ...... to Selective Jak3 Inhibitors.

@en

P2093

G Steven Martinez

http://www.w3.org/2001/XMLSchema#string

Jeremy A Ross

http://www.w3.org/2001/XMLSchema#string

Robert A Kirken

http://www.w3.org/2001/XMLSchema#string

P2860

JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model

Uncoupling JAK3 activation induces apoptosis in human lymphoid cancer cells via regulating critical survival pathways.

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials.

Array-based genomic resequencing of human leukemia.

Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies.

Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity

JAK mutations in high-risk childhood acute lymphoblastic leukemia

Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies

Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside.

P304

131-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/2212697X03666160610085943

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29046866

http://www.w3.org/2001/XMLSchema#string

P932

5642970

http://www.w3.org/2001/XMLSchema#string

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors.

about

P2860

P2860

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932